Analysed HEART TEST LABORATORIES-CW27 (HSCSW:NASDAQ) News Sources
HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting
14-04-2026
yahoo.com
HeartSciences’ MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category
25-03-2026
yahoo.com
HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings
24-03-2026
yahoo.com
Investor Summit Announces Q1 Presenter Line Up (Presentations 3/25, 1-on-1s 3/26)
20-03-2026
yahoo.com
HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
16-03-2026
yahoo.com
HeartSciences Inc. (HSCS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
21-10-2025
yahoo.com
HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results
11-09-2025
yahoo.com
Presenting on Emerging Growth Conference 85 Day 1 on August 20; Register to live stream
19-08-2025
yahoo.com
What is the current price of HEART TEST LABORATORIES-CW27 (HSCSW:NASDAQ)?
The current price of HEART TEST LABORATORIES-CW27 (HSCSW:NASDAQ) is $0.0648.
HEART TEST LABORATORIES-CW27 (HSCSW:NASDAQ) absolute price change since previous trading day?
The absolute price change of HEART TEST LABORATORIES-CW27 (HSCSW:NASDAQ) since the previous trading day is $0.0038.
HEART TEST LABORATORIES-CW27 (HSCSW:NASDAQ) percentage price change since previous trading day?
The percentage price change of HEART TEST LABORATORIES-CW27 (HSCSW:NASDAQ) since the previous trading day is 6.2295%.
What is the most recent average sentiment score for HEART TEST LABORATORIES-CW27 (HSCSW:NASDAQ)?
The most recent average sentiment score for HEART TEST LABORATORIES-CW27 (HSCSW:NASDAQ) is 59 out of 100.
What is the most recent average sentiment for HEART TEST LABORATORIES-CW27 (HSCSW:NASDAQ)?
The most recent sentiment for HEART TEST LABORATORIES-CW27 (HSCSW:NASDAQ) is .
SEC-8K** Filing Available For HEART TEST LABORATORIES-CW27 (HSCSW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.